National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

bromodeoxyuridine
A halogenated thymidine analogue with potential antineoplastic and radiosensitizing activities. Bromodeoxyuridine competes with thymidine for incorporation into DNA, resulting in DNA mutation and the inhibition of cell proliferation. As a radiosensitizer, this agent is associated with the inhibition of repair of radiation-induced DNA double-strand breaks (DSBs). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:5-bromodeoxyuridine
broxuridine
Abbreviations:5-BrdU
BrdU
Chemical structure name:5-bromouracil-2-deoxyriboside



Previous:brivanib alaninate, broad-spectrum human papillomavirus vaccine V505, broccoli sprout extract, bromelain, bromocriptine mesylate
Next:bromovinyl-deoxyuridine, brostallicin, bruceantin, bryostatin 1, budesonide/formoterol fumarate dihydrate inhalation aerosol

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov